TuHURA Operating Cycle from 2010 to 2026
| HURA Stock | 1.29 0.01 0.77% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 604.31 | Current Value 537.16 | Quarterly Volatility 35.49251776 |
Check TuHURA Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TuHURA Biosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 10.2 M, Total Operating Expenses of 10.2 M or Depreciation And Amortization of 140.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0187 or PTB Ratio of 4.94. TuHURA financial statements analysis is a perfect complement when working with TuHURA Biosciences Valuation or Volatility modules.
TuHURA | Operating Cycle | Build AI portfolio with TuHURA Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:Check out the analysis of TuHURA Biosciences Correlation against competitors. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. Market participants price TuHURA higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive TuHURA Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding TuHURA Biosciences requires distinguishing between market price and book value, where the latter reflects TuHURA's accounting equity. The concept of intrinsic value - what TuHURA Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push TuHURA Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, TuHURA Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.